Your browser is no longer supported. Please, upgrade your browser.
Settings
GSK GlaxoSmithKline plc daily Stock Chart
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E25.34 EPS (ttm)1.54 Insider Own0.20% Shs Outstand2.46B Perf Week0.05%
Market Cap96.05B Forward P/E13.71 EPS next Y2.85 Insider Trans0.00% Shs Float2.46B Perf Month3.09%
Income3.82B PEG2.61 EPS next Q0.67 Inst Own11.50% Short Float0.32% Perf Quarter-4.40%
Sales39.29B P/S2.44 EPS this Y184.00% Inst Trans0.68% Short Ratio2.08 Perf Half Y-4.57%
Book/sh2.36 P/B16.56 EPS next Y-5.85% ROA3.30% Target Price43.84 Perf Year1.32%
Cash/sh2.05 P/C19.10 EPS next 5Y9.70% ROE92.90% 52W Range34.89 - 42.36 Perf YTD2.25%
Dividend1.96 P/FCF26.55 EPS past 5Y-10.10% ROI22.90% 52W High-7.77% Beta0.79
Dividend %5.02% Quick Ratio0.60 Sales past 5Y2.70% Gross Margin68.80% 52W Low11.98% ATR0.65
Employees98462 Current Ratio0.90 Sales Q/Q3.20% Oper. Margin14.90% RSI (14)52.34 Volatility1.17% 1.45%
OptionableYes Debt/Eq6.19 EPS Q/Q16.10% Profit Margin6.20% Rel Volume0.72 Prev Close38.97
ShortableYes LT Debt/Eq5.54 EarningsFeb 06 Payout162.80% Avg Volume3.79M Price39.07
Recom2.00 SMA201.43% SMA50-0.09% SMA200-2.41% Volume2,723,214 Change0.26%
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Aug-30-18Downgrade Liberum Buy → Hold
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Sep-08-17Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-05-17Downgrade Citigroup Buy → Neutral
May-26-17Upgrade Berenberg Hold → Buy
Apr-05-17Upgrade Exane BNP Paribas Underperform → Neutral
Mar-09-17Initiated Liberum Buy
Mar-09-17Initiated Kepler Reduce
Oct-20-16Initiated Investec Buy
Sep-23-16Initiated Piper Jaffray Overweight
Jul-14-16Upgrade Jefferies Hold → Buy
Mar-30-16Upgrade Citigroup Neutral → Buy
Feb-26-16Initiated Cantor Fitzgerald Hold
Jan-24-19 12:14AM  Should You Be Impressed By GlaxoSmithKline plcs (LON:GSK) ROE? Simply Wall St.
Jan-23-19 08:16AM  3 Upcoming Readouts for Gilead Sciences You Don't Want to Miss Motley Fool
Jan-22-19 08:01AM  Why Should You Hold Genpact (G) Stock in Your Portfolio? Zacks
Jan-21-19 08:06PM  PRESS DIGEST- Financial Times - Jan 22 Reuters
07:55AM  The Drugs Aren't Working Yet for GlaxoSmithKline Bloomberg
05:32AM  [$$] GSK Chairman Hampton to Leave The Wall Street Journal
03:38AM  [$$] Taxi for Just Eat CEO as Uber and Deliveroo serve up competition Financial Times
03:16AM  GSK Chairman Hampton to step down ahead of split Reuters
03:05AM  GSK Chairman Hampton to step down ahead of split Reuters
02:34AM  GSK Chairman Hampton to step down Reuters
01:01AM  [$$] GSK chairman to step down ahead of break-up Financial Times
Jan-16-19 08:58PM  Banks Are Leading: Cramer's 'Mad Money' Recap (Wednesday 1/16/19) TheStreet.com
Jan-11-19 12:19PM  GSK Foundation awards UNC $1M American City Business Journals
09:45AM  Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet Zacks
09:36AM  New Strong Sell Stocks for January 11th Zacks
06:22AM  4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019 Zacks
Jan-10-19 09:56AM  Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting Zacks
Jan-09-19 07:02PM  MoCo economic development officials plan satellite office in Boston American City Business Journals
08:51AM  The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Lilly and Glaxo Zacks
Jan-08-19 05:20PM  Emergent (EBS) Up on '19 View, Posts Preliminary '18 Results Zacks
03:17PM  Get Ready to Buy the Big Upside Breakout on GlaxoSmithKline TheStreet.com
12:12PM  GlaxoSmithKline to look for early-stage assets - CEO Reuters
09:52AM  Crowded Cancer Space Triggers Big M&A Deals: More in Store? Zacks
07:15AM  3 Companies You Don't Realize You Rely On Every Day Motley Fool
Jan-07-19 06:12PM  Cramer: Drug stocks are an even better way than tech to invest in innovation CNBC
01:05PM  GlaxoSmithKline CEO Emma Walmsley gets 'radical' about reshaping portfolio CNBC
11:47AM  GSK CEO: Pfizer venture creates value for both our consum... CNBC Videos
Jan-04-19 07:50AM  Britains Fat Cat Bosses Get Rich Far Too Quickly Bloomberg
06:17AM  Merck Buys NASH Candidate, Keytruda Wins 5 Approvals in Japan Zacks
Jan-03-19 12:35PM  3 Biopharma Stocks to Buy for Their Robust Dividend Yields InvestorPlace
09:07AM  The Zacks Analyst Blog Highlights: Facebook, Wells Fargo, AT&T, Intel and Glaxo Zacks
Dec-31-18 08:31AM  Novartis (NVS) Benefits From New Drugs & Key Acquisitions Zacks
08:10AM  Emergent (EBS) Files Application for Emergency Use of NuThrax Zacks
03:51AM  UK markets rise as the curtain falls on a dim 2018 Reuters
Dec-29-18 08:02AM  Forget GlaxoSmithKline, Eli Lilly Is a Better Big Pharma Stock Motley Fool
Dec-27-18 09:23AM  Stocks down in December for pharma firms in the Triangle American City Business Journals
Dec-26-18 04:43PM  How to Save $650 Million Without Really Trying Motley Fool
03:23PM  Should You Buy PFE Stock on Pfizers Joint Venture With Glaxo? InvestorPlace
Dec-21-18 05:50PM  GlaxoSmithKline (GSK) Stock Moves -0.84%: What You Should Know Zacks
11:21AM  Former P&G manager named CEO of $12B joint venture American City Business Journals
10:26AM  GlaxoSmithKline Capital Inc. -- Moody's affirms GSK's A2 ratings; outlook remains negative Moody's
09:13AM  Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations Zacks
08:57AM  Merck's sBLA for Keytruda in Lung Cancer Gets Extended Review Zacks
08:51AM  Novartis (NVS) Offers to Buy French Gene Therapy Manufacturer Zacks
05:04AM  [$$] European Forex and Fixed Income Market Talk Roundup The Wall Street Journal
03:54AM  [$$] European Equities Market Talk Roundup The Wall Street Journal
Dec-20-18 01:42PM  Commentary: GSK, Pfizer and GE shift away from diversification in latest round of health-care deals CNBC
09:30AM  Company News For Dec 20, 2018 Zacks
Dec-19-18 10:43PM  [$$] Pfizer, Glaxo to Create Over-the-Counter Drug Giant The Wall Street Journal
08:48PM  PRESS DIGEST- British Business - Dec 20 Reuters
08:08PM  Major pharma companies plan to raise drug prices in January: report MarketWatch
07:50PM  PRESS DIGEST- Financial Times - Dec 20 Reuters
07:41PM  [$$] Pfizer, Glaxo Strike Deal to Put Focus on Prescription Drugs The Wall Street Journal
04:52PM  GlaxoSmithKline and General Mills climb while FedEx drops Associated Press
04:36PM  Stocks Hit New Lows After Early Rally as Fed Hikes Key Rate TheStreet.com
04:22PM  Glaxo Stock Pops On Pfizer Deal To Merge Consumer Health Units Investor's Business Daily
02:15PM  Pfizer Inc. -- Moody's: Pfizer's JV formation with GSK is credit negative Moody's
02:07PM  GlaxoSmithKline, Pfizer Team Up to Form New Joint Venture GuruFocus.com
01:18PM  Glaxo, Pfizer to merge consumer health care divisions Associated Press
12:25PM  GSK pulls FTSE 100 out of three-day rut, focus on Fed Reuters
12:01PM  GlaxoSmithKline, Pfizer To Merge Consumer Health Care Businesses Benzinga
11:48AM  GlaxoSmithKline (GSK) Stock Pops on Pfizer Joint Venture InvestorPlace
11:20AM  Glaxo Creates a Consumer Behemoth and a Pharma Question Mark Bloomberg
11:08AM  Pfizer Deal With Glaxo Shows Drug Giants Turning Back to the Lab Bloomberg
11:07AM  Big Pharma Cures Its Consumer Headache by Splitting Off Painkillers Bloomberg
10:16AM  Pfizer inks deal to bring Advil and Excedrin under one roof American City Business Journals
09:57AM  [$$] Debt Is the Tonic in GSK and Pfizer's Big Deal The Wall Street Journal
09:38AM  Stocks Open Higher: Fed Rate Hike Vote, A Dow Jones Merger Investor's Business Daily
09:37AM  GSK, Pfizer create consumer health giant Reuters Videos
09:25AM  Glaxo, Pfizer to Merge Consumer Health Units, Form New JV Zacks
08:45AM  Market Morning: Rate Hike Trade Guide, Mnuchin Blames HFTs, Musk Unveils Boring Hole, Facebook Claims Consent Market Exclusive
08:36AM  Glaxo-Pfizer Deal Creates Biggest Over-the-Counter Drug Supplier Bloomberg
08:30AM  Fed, Micron, Glaxo and Pfizer, FedEx and Facebook - 5 Things You Must Know TheStreet.com
08:07AM  GSK & Pfizer to combine consumer health businesses American City Business Journals
07:37AM  Pfizer consumer health deal will help fuel investments in pharma, vaccines, says GSK CEO CNBC
07:37AM  Pfizer consumer health deal will help fuel investments in pharma, vaccines, GSK CEO says CNBC
07:20AM  GSK CEO on Pfizer deal: Separation should happen within 3... CNBC Videos
07:17AM  Drugmaker GSK to split after striking Pfizer consumer health deal Reuters
07:10AM  [$$] European Equities Market Talk Roundup The Wall Street Journal
07:03AM  Dow futures higher | Fed rate decision set | Pfizer, GSK agree to $12.7 billion deal CNBC
05:35AM  Drugmaker GSK to split after striking Pfizer consumer health deal Reuters
05:10AM  Reckitt Can Still Make it to the Glaxo-Pfizer Party Bloomberg
04:28AM  Drugmaker GSK to split after striking Pfizer consumer health deal Reuters
04:03AM  GlaxoSmithKline, Pfizer Form Consumer Healthcare Group With $13 Billion in Sales TheStreet.com
03:12AM  Europe Stocks Steady on Italy Budget News; Glaxo Jumps on Merger Bloomberg
02:37AM  [$$] GlaxoSmithKline, Pfizer to Create Consumer Healthcare JV The Wall Street Journal
02:03AM  Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company Business Wire
Dec-18-18 07:40AM  Heres an evergreen strategy to make money in a volatile stock market MarketWatch
Dec-17-18 03:10PM  IBD 50 Stocks To Watch: Innoviva Resilient As Broad Market Struggles Investor's Business Daily
03:10PM  Charlotte developer buys 105 acres from GSK for RTP spec campus American City Business Journals
01:14PM  Activist Pushing Cancer Drugmaker Clovis to Pursue Sale Bloomberg
Dec-13-18 05:18PM  Targeting 'bubble baby' disease, this gene therapy company is planting a flag in the East Bay American City Business Journals
01:00AM  Big Pharma Grants License to Kill Drug Programs as Costs Surge Bloomberg
Dec-12-18 08:15AM  3 Dividend Stocks That Pay You More Than Exxon Does Motley Fool
Dec-11-18 12:42PM  Gabelli Names Clovis As Top Pick, Calls The Biotech A Likely Takeout Candidate Benzinga
05:01AM  Is GlaxoSmithKline plc (GSK) A Good Stock To Buy? Insider Monkey
Dec-10-18 01:59PM  Here's Why Tesaro Rose 60.6% in November -- and Another 60% Since Motley Fool
Dec-08-18 08:09PM  Is Bristol Myers Squibb Co. (BMY) A Good Stock To Buy According To Hedge Funds? Insider Monkey
05:36PM  Could These Be the Next 2 Biotech Buyouts? Motley Fool
Dec-07-18 06:58PM  Cramer's lightning round: There are better drug stocks to... CNBC Videos
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; and a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology. GlaxoSmithKline plc also has a joint research collaboration with Fimbrion Therapeutics Inc. to develop a small molecule candidate for the treatment and prevention of urinary tract infections. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLCFormer 10% holderJul 30Buy11.00148,8181,636,998624,422Aug 01 06:32 PM
GLAXOSMITHKLINE PLC10% OwnerJul 17Buy12.5080,0001,000,0001,934,006Jul 17 05:01 PM
GLAXOSMITHKLINE PLC10% OwnerJul 02Buy13.00269,2303,499,9903,697,912Jul 03 05:59 PM